News Overview

There was not much in the budget for mutual funds, as most of the expectations did not really materialize

There was a lot of hue and cry over the STT increase, but that would only be a part of the overall capital market implications

There was not much for the people to cheer about on the direct tax front, but then a lot has already been done

Along expected lines, the Union Budget has expanded defence spending and kept the fisc in control

As India presented the Union Budget 2026, market participants approached the policy event with a measured mix of caution and focus, shaped by a decade of uneven equity market reactions to budget announcements.

The change is aimed at simplifying the investment process for overseas based Indians and improving ease of access to India’s domestic capital markets.

According to the Finance Minister, the Bio Pharma Shakti initiative is designed to support research, manufacturing capacity, innovation, and scale across the bio pharma value chain.

Revenue from operations for the quarter slipped 2.7% year on year to ₹34,075.8 crore, down from ₹35,031.2 crore recorded in the year ago period

Earnings before interest, tax, depreciation, and amortisation more than doubled to ₹208.5 crore in Q3 FY26 from ₹103 crore reported a year earlier.

Earnings before interest, tax, depreciation and amortisation rose 18% year on year to ₹292.5 crore, up from ₹247.7 crore reported in Q3 of the previous financial year.